James M. McKim
Plus aucun poste en cours
Profil
James M.
McKim was the founder of Lab Pathways, Inc. (founded in 2003) and Iontox, Inc. (founded in 2013) where he held the titles of Chief Scientific Officer and President, respectively.
He also held former positions as Principal at Dow Silicones Corp.
and Pharmacia Corp.
Additionally, he has an undergraduate degree from Oregon State University and a doctorate from the University of Kansas.
Anciens postes connus de James M. McKim
| Sociétés | Poste | Fin |
|---|---|---|
Iontox, Inc.
 Iontox, Inc. Miscellaneous Commercial ServicesCommercial Services Iontox, Inc. operates as an biotechnology company. The company was founded by James McKim in 2013 and is headquartered in Kalamazoo, MI. | Fondateur | - |
| University of Kansas | Directeur en chef des Investissements | 20/01/2010 |
Dow Silicones Corp.
 Dow Silicones Corp. Chemicals: SpecialtyProcess Industries Dow Silicones Corp. engages in the provision of silicones products and solutions. Its silicon-based materials are used in products and applications of sectors including electronics, automotive, construction, textiles, and healthcare. The company was founded in 1943 and is headquartered in Midland, MI. | Corporate Officer/Principal | - |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | - |
Lab Pathways, Inc.
 Lab Pathways, Inc. Miscellaneous Commercial ServicesCommercial Services Lab Pathways, Inc. was founded in July of 2003 as a Contract Research Organization focused on in vitro toxicity screening of potential drug candidates and chemicals. CeeTox resides in 4,200-square-feet of state-of-the-art laboratory space in the Southwest Michigan Innovation Center (SMIC), a $13 million facility that serves as an incubator for new biotech companies in the Southwest Michigan area. In 2010, CeeTox purchased certain assets formerly owned by ADMETRx Inc. This asset purchase increases CeeTox's existing ADME capabilities and is yet another step in its strategy to expand its range of in vitro service offerings. The scientists at CeeTox have a collective experience of more than 100 years in areas of cell culture, biochemistry, and toxicology. The team has analyzed more than 4,000 new chemical entities and has repeatedly demonstrated the value of early in vitro toxicity data in the drug discovery process. | Fondateur | - |
Formation de James M. McKim
| Oregon State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Dow Silicones Corp.
Dow Silicones Corp. Chemicals: SpecialtyProcess Industries Dow Silicones Corp. engages in the provision of silicones products and solutions. Its silicon-based materials are used in products and applications of sectors including electronics, automotive, construction, textiles, and healthcare. The company was founded in 1943 and is headquartered in Midland, MI. | Process Industries |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Lab Pathways, Inc.
Lab Pathways, Inc. Miscellaneous Commercial ServicesCommercial Services Lab Pathways, Inc. was founded in July of 2003 as a Contract Research Organization focused on in vitro toxicity screening of potential drug candidates and chemicals. CeeTox resides in 4,200-square-feet of state-of-the-art laboratory space in the Southwest Michigan Innovation Center (SMIC), a $13 million facility that serves as an incubator for new biotech companies in the Southwest Michigan area. In 2010, CeeTox purchased certain assets formerly owned by ADMETRx Inc. This asset purchase increases CeeTox's existing ADME capabilities and is yet another step in its strategy to expand its range of in vitro service offerings. The scientists at CeeTox have a collective experience of more than 100 years in areas of cell culture, biochemistry, and toxicology. The team has analyzed more than 4,000 new chemical entities and has repeatedly demonstrated the value of early in vitro toxicity data in the drug discovery process. | Commercial Services |
Iontox, Inc.
Iontox, Inc. Miscellaneous Commercial ServicesCommercial Services Iontox, Inc. operates as an biotechnology company. The company was founded by James McKim in 2013 and is headquartered in Kalamazoo, MI. | Commercial Services |